SYQUANT CAPITAL SAS Quant / Systematic

Location: Paris, France

CIK: 0001766392 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: Apr 12, 2023

Total Value: $43.16M

Holdings (7)

— HORIZON THERAPEUTICS PUB L 68.7%

Value $29.64M Shares 271,617 Est. Cost $109.14 Unrealized —

— MONEYGRAM INTL INC 10.8%

Value $4.67M Shares 448,200 Est. Cost $10.42 Unrealized —

— AMRYT PHARMA PLC 8.7%

Value $3.762M Shares 258,000 Est. Cost $14.58 Unrealized —

— APOLLO ENDOSURGERY INC 6.9%

Value $2.976M Shares 300,000 Est. Cost $9.92 Unrealized —

MANU MANCHESTER UTD PLC NEW 2.6%

Value $1.108M Shares 50,000 Est. Cost — Unrealized —

FTI TECHNIPFMC PLC 1.7%

Value $723K Shares 53,000 Est. Cost $8.02 Unrealized +65.8%

RACE FERRARI N V 0.6%

Value $273K Shares 1,010 Est. Cost $255.40 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	HORIZON THERAPEUTICS PUB L	271,617	$29.64M	68.7%	$109.14	—	—	G46188101
—	MONEYGRAM INTL INC	448,200	$4.67M	10.8%	$10.42	—	—	60935Y208
—	AMRYT PHARMA PLC	258,000	$3.762M	8.7%	$14.58	—	—	03217L106
—	APOLLO ENDOSURGERY INC	300,000	$2.976M	6.9%	$9.92	—	—	03767D108
MANU	MANCHESTER UTD PLC NEW	50,000	$1.108M	2.6%	—	—	CALL	G5784H106
FTI	TECHNIPFMC PLC	53,000	$723K	1.7%	$8.02	+65.8%	—	G87110105
RACE	FERRARI N V	1,010	$273K	0.6%	$255.40	0.0%	—	N3167Y103